LON:SBTX SkinBioTherapeutics (SBTX) Share Price, News & Analysis GBX 11.88 -0.43 (-3.46%) (As of 09/6/2024 12:25 PM ET) Add Compare Share Share Today's Range 11.62▼ 12.2050-Day Range 8.50▼ 14.2552-Week Range 7▼ 29.50Volume1.68 million shsAverage Volume797,696 shsMarket Capitalization£26.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get SkinBioTherapeutics alerts: Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About SkinBioTherapeutics Stock (LON:SBTX)SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.Read More SBTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBTX Stock News HeadlinesJuly 20, 2024 | finance.yahoo.comProBiotix Health Plc (PBX.AQ)May 1, 2024 | ca.finance.yahoo.comSkinBioTherapeutics plc (SBTX.L)September 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. March 26, 2024 | finance.yahoo.comSkinBioTherapeutics First Half 2024 Earnings: UK£0.008 loss per share (vs UK£0.008 loss in 1H 2023)March 18, 2024 | lse.co.ukSkinBioTherapeutics announces research into wound healing bacteriumNovember 17, 2023 | uk.investing.comSkinBioTherapeutics bags £3m at a modest discountNovember 16, 2023 | marketwatch.comSkinBioTherapeutics to Raise at Least $3.7 MlnSeptember 14, 2023 | uk.investing.comFiverr International Ltd DRC (F2VR34)September 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. September 2, 2023 | uk.investing.comSocietatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA (ROH2O)July 11, 2023 | finance.yahoo.comSBTX.L - SkinBioTherapeutics PlcJune 21, 2023 | marketwatch.comSkinBioTherapeutics Gets Approval for Supplement Launch in ItalyMarch 30, 2023 | finance.yahoo.comSkinBioTherapeutics Reports First Half 2023 EarningsMarch 28, 2023 | marketwatch.comSkinBioTherapeutics Shares Fall on Widened 1H Pretax Loss From Higher CostsMarch 22, 2023 | finance.yahoo.comIs SkinBioTherapeutics (LON:SBTX) In A Good Position To Invest In Growth?December 21, 2022 | marketwatch.comSkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail OfferDecember 15, 2022 | marketwatch.comSkinBioTherapeutics to Raise a Minimum of GBP2.5 MlnOctober 14, 2022 | finance.yahoo.comAfter losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gainSee More Headlines Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/03/2020Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SBTX CUSIPN/A CIKN/A Webwww.skinbiotherapeutics.com Phone+44-161-4682760FaxN/AEmployees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,880,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-118.63% Return on Assets-61.18% Debt Debt-to-Equity Ratio2.66 Current Ratio6.57 Quick Ratio10.01 Sales & Book Value Annual Sales£21,949.00 Price / Sales1,223.21 Cash FlowGBX 1.32 per share Price / Cash Flow9.00 Book ValueGBX 2 per share Price / Book5.94Miscellaneous Outstanding Shares226,090,000Free FloatN/AMarket Cap£26.85 million OptionableNot Optionable Beta2.01 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Stuart John Ashman (Age 58)CEO & Executive Director Comp: $371.1kMr. Manprit Singh Randhawa (Age 41)CFO, Secretary & Director Comp: $261.48kLaura BeyHead of FormulationsMs. Melissa GreenwellGroup Financial ControllerKey CompetitorsFutura MedicalLON:FUMVerseonLON:VSNMereo BioPharma Group plc (MPH.L)LON:MPHOpen OrphanLON:ORPHPoolbeg PharmaLON:POLBView All Competitors SBTX Stock Analysis - Frequently Asked Questions How have SBTX shares performed this year? SkinBioTherapeutics' stock was trading at GBX 15.25 on January 1st, 2024. Since then, SBTX stock has decreased by 22.1% and is now trading at GBX 11.88. View the best growth stocks for 2024 here. How were SkinBioTherapeutics' earnings last quarter? SkinBioTherapeutics plc (LON:SBTX) issued its quarterly earnings data on Tuesday, March, 3rd. The company reported ($0.64) EPS for the quarter. How do I buy shares of SkinBioTherapeutics? Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of SkinBioTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG) and Big Sofa Technologies Group (BST). This page (LON:SBTX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.